Article
Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations.
PloS one - 1 Jan 2017
Ordelheide Anna-Maria, Böhm Anja, Kempe-Teufel Daniela, Wagner Robert, Machicao Fausto, Heni Martin, Stefan Norbert, Fritsche Andreas, Häring Hans-Ulrich, Staiger Harald
Abstract excerpt
AIM: Inhibition of sodium/glucose cotransporter 2 (SGLT2), the key transport protein in renal glucose reabsorption, promotes glucose excretion and represents a new concept in the therapy of type-2 diabetes. In addition, SGLT2 inhibition elevates circulating glucagon concentrations and enhances hepatic glucose production. Since SGLT2 is expressed in human pancreatic α-cells and regulates glucagon release, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
